Edgewise Therapeutics (EWTX) EPS (Basic) (2020 - 2026)
Edgewise Therapeutics (EWTX) reported EPS (Basic) of -$0.46 for Q1 2026, down 6.69% on a YoY basis from -$0.49 in Q1 2025, and up 84.61% sequentially from -$2.97 in Q4 2025.
Edgewise Therapeutics (EWTX) EPS (Basic) (2020 - 2026) Analysis & Trends
Edgewise Therapeutics (EWTX) has 7 years of EPS (Basic) data on file, last reported at -$0.46 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 6.69% year-over-year to -$0.46; the trailing twelve-month figure through Mar 2026 stood at -$4.03 (up 7.51% YoY), and the FY2025 full-year result was -$4.11, up 5.22% from the prior year.
- EPS (Basic) improved to -$0.46 in Q1 2026, from -$2.97 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.33 in Q2 2022 to a low of -$3.32 in Q4 2024.
- A 5-year average of -$0.72 and a median of -$0.4 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) jumped 91.7% in 2022 and tumbled 601.18% in 2024, its largest moves.
- Tracing EWTX's EPS (Basic) over 5 years: stood at -$0.37 in 2022, then fell by 27.96% to -$0.47 in 2023, then plunged by 601.18% to -$3.32 in 2024, then rose by 10.54% to -$2.97 in 2025, then surged by 84.61% to -$0.46 in 2026.
- Business Quant data shows EWTX's EPS (Basic) at -$0.46 in Q1 2026, -$2.97 in Q4 2025, and -$0.39 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Edgewise Therapeutics | 4.37 Bn | 4.37 Bn | - | -0.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.46 |
| Dec 31, 2025 | -2.97 |
| Sep 30, 2025 | -0.39 |
| Jun 30, 2025 | -0.34 |
| Mar 31, 2025 | -0.43 |
| Dec 31, 2024 | -3.32 |
| Sep 30, 2024 | -0.36 |
| Jun 30, 2024 | -0.35 |
| Mar 31, 2024 | -0.40 |
| Dec 31, 2023 | -0.47 |
| Sep 30, 2023 | -0.43 |
| Jun 30, 2023 | -0.45 |
| Mar 31, 2023 | -0.47 |
| Dec 31, 2022 | -0.37 |
| Sep 30, 2022 | -0.35 |
| Jun 30, 2022 | -0.33 |
| Mar 31, 2022 | -0.36 |
| Dec 31, 2021 | -0.89 |
| Sep 30, 2021 | -0.26 |
| Jun 30, 2021 | -0.21 |